NEOG
Neogen Corporation
NASDAQ: NEOG · HEALTHCARE · MEDICAL DEVICES
$9.40
+4.33% today
Updated 2026-04-30
Market cap
$1.96B
P/E ratio
—
P/S ratio
2.25x
EPS (TTM)
$-2.80
Dividend yield
—
52W range
$5 – $11
Volume
2.7M
Neogen Corporation (NEOG) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-69.90%
Operating margin
-1.56%
ROE
-25.60%
ROA
-0.61%
Debt/equity
0.38x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $72.43M | $7.94M | 51.09% | 14.92% | 10.96% |
| 2007 | $86.14M | $9.13M | 51.73% | 15.68% | 10.59% |
| 2008 | $102.42M | $12.10M | 51.98% | 17.59% | 11.81% |
| 2009 | $118.72M | $13.87M | 50.06% | 17.26% | 11.69% |
| 2010 | $140.51M | $17.52M | 51.94% | 19.13% | 12.47% |
| 2011 | $172.68M | $22.84M | 50.84% | 20.75% | 13.23% |
| 2012 | $184.05M | $22.51M | 50.22% | 18.33% | 12.23% |
| 2013 | $207.53M | $27.19M | 52.76% | 19.61% | 13.10% |
| 2014 | $247.41M | $28.16M | 49.55% | 17.54% | 11.38% |
| 2015 | $283.07M | $33.53M | 49.35% | 18.76% | 11.84% |
| 2016 | $321.27M | $36.56M | 47.64% | 17.55% | 11.38% |
| 2017 | $361.59M | $43.79M | 47.56% | 17.96% | 12.11% |
| 2018 | $402.25M | $63.15M | 47.30% | 17.45% | 15.70% |
| 2019 | $414.19M | $60.18M | 46.34% | 16.44% | 14.53% |
| 2020 | $418.17M | $59.48M | 46.94% | 16.15% | 14.22% |
| 2021 | $468.46M | $60.88M | 45.91% | 15.83% | 13.00% |
| 2022 | $527.16M | $48.31M | 46.10% | 11.12% | 9.16% |
| 2023 | $822.45M | $-22.87M | 49.36% | 4.56% | -2.78% |
| 2024 | $924.22M | $-9.42M | 50.06% | 8.38% | -1.02% |
| 2025 | $894.66M | $-1.09B | 47.10% | 1.05% | -122.06% |